Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
United States | Publication | February 2022
Norton Rose Fulbright lawyers Roger Kuan and Jason Novak contributed several chapters to Digital Health 2022 International Comparative Legal Guide, published by GLG, which is a leading global platform for legal reference, analysis and news. Kuan also served as a contributing editor for the publication.
Authors: Roger Kuan, Norton Rose Fulbright and David Wallace, Johnson & Johnson
As an introduction into digital health, Kuan expands on the digital technologies in healthcare including healthcare IT, data use, data sharing, intellectual property, commercial agreements, AI and machine learning and liability and the acceleration transformation that was experienced during the pandemic.
Authors: Jason Novak, Norton Rose Fulbright and René Quashie, Consumer Technology Association
Novak explores Digital Therapeutics (DTx), an innovative subset of digital health that has quickly become a new platform for addressing treatment, management and prevention of various disease, as well as any legal and regulatory issues that may arise.
Authors: Roger Kuan and Jason Novak, Norton Rose Fulbright
In this chapter, Kuan and Novak provide answers to key questions regarding digital health and emerging technologies.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023